Certara (NASDAQ: CERT)
$17.00
(-0.4%)
-$0.06
Price as of May 10, 2024, 4:00 p.m. ET
Certara Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Certara Company Info
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Princeton, NJ.
Valuation
Earnings Transcripts
Certara, Inc. (CERT) Q2 2022 Earnings Call Transcript
CERT earnings call for the period ending June 30, 2022.
Motley Fool Transcribing | Aug 9, 2022
Certara, Inc. (CERT) Q1 2022 Earnings Call Transcript
CERT earnings call for the period ending March 31, 2022.
Motley Fool Transcribing | May 5, 2022
Certara, Inc. (CERT) Q4 2021 Earnings Call Transcript
CERT earnings call for the period ending December 31, 2021.
Motley Fool Transcribing | Mar 1, 2022
Certara, Inc. (CERT) Q3 2021 Earnings Call Transcript
CERT earnings call for the period ending September 30, 2021.
Motley Fool Transcribing | Nov 10, 2021
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.